Consequently, recognition of tumor cells by CAR T-cells could be hampered by soluble BCMA as a result of reducing BCMA density on the tumor cell surface and/or blocking the antigen-binding domain of the CAR. The gene discussed is TNFRSF17; the disease is neoplasm.